Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients
-
Published:2021-04-19
Issue:1
Volume:125
Page:119-125
-
ISSN:0007-0920
-
Container-title:British Journal of Cancer
-
language:en
-
Short-container-title:Br J Cancer
Author:
Ko Sung Min, Lee Janghee, Bae Soong June, Baik Su Jung, Ji Junghwan, Kim Dooreh, Ahn Sung GweORCID, Jeong JoonORCID
Abstract
Abstract
Background
Our study evaluated the association between body mass index (BMI) and absolute lymphocyte count (ALC) in breast cancer patients and healthy females. Additionally, we determined the prognostic value of these factors in breast cancer.
Methods
We retrospectively identified 1225 primary invasive breast cancer patients and 35,991 healthy females. Factors including BMI and complete blood count associated with disease-free survival (DFS) were assessed using a multi-variable Cox proportional hazard model.
Results
BMI and ALC were positively correlated in breast cancer patients and healthy females (both P < 0.001). In multi-variable analysis, overweight or obese participants had worse DFS (hazards ratio [HR], 1.98; 95% confidence interval [CI], 1.34–2.92; P = 0.001) than underweight or normal-weight individuals, but patients with high ALC had better DFS than those with low ALC (HR, 0.43; 95% CI, 0.29–0.65; P < 0.001). After risk stratification according to BMI/ALC, high-risk patients with high BMI/low ALC had worse DFS than others (HR, 2.48; 95% CI, 1.70–3.62; P < 0.001).
Conclusions
BMI and ALC were positive correlated, but their effect on breast cancer prognosis was opposite. Patients with high BMI/low ALC had worse DFS than others. Underlying mechanisms for effect of BMI/ALC on breast cancer prognosis should be studied in the future.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Reference33 articles.
1. Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Rebelo, M. et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base no. 11. (International Agency for Research on Cancer, 2014). 2. Jung, K. W., Won, Y. J., Kong, H. J. & Lee, E. S. Cancer Statistics in Korea: Incidence, mortality, survival, and prevalence in 2016. Cancer Res. Treat. 51, 417–430 (2019). 3. Key, T. J., Verkasalo, P. K. & Banks, E. Epidemiology of breast cancer. Lancet Oncol. 2, 133–140 (2001). 4. Stuart-Harris, R., Caldas, C., Pinder, S. E. & Pharoah, P. Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients. Breast (Edinb., Scotl.) 17, 323–334 (2008). 5. Song, H. J., Hwang, J., Pi, S., Ahn, S., Heo, Y., Park, S. et al. The impact of obesity and overweight on medical expenditures and disease incidence in Korea from 2002 to 2013. PLoS ONE 13, e0197057 (2018).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|